Home › Funds › PSP Research LLC › VERA

PSP Research LLC position in VERA

VERA THERAPEUTICS INC · Health Care

PSP Research LLC reported holding 7,000 shares of VERA (VERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$300K, representing 0.16% of its reported portfolio and ranking #49 among its reported holdings. PSP Research LLC has disclosed VERA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)7.00K sh
Reported value held$300.37K
Portfolio Weight0.16%
First reportedQ4 2025
Last changeNew

How PSP Research LLC's VERA position evolved

PSP Research LLC first disclosed a stake in VERA in Q4 2025 at 9,996 shares (US$506K). Across 3 filings, PSP Research LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 7,000 shares valued at US$300K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 10.00K $506.20K New
Q1 2026 10.00K $402.30K Hold
Q2 2026 7.00K $300.37K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VERA and 13F data

VERA (VERA THERAPEUTICS INC) is a Health Care company. 40 other funds we track also report a position in VERA — the largest reported positions include Avoro Capital Advisors LLC (US$245.6M), Deep Track Capital, LP (US$171.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$168.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VERA

All VERA fund holders →